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ABSTRACT  25 
 26 
A novel burn wound hydrogel dressing has been previously developed which is composed 27 
of 2-acrylamido-2-methylpropane sulfonic acid sodium salt with silver nanoparticles (silver 28 
AMPS). This study compared the cytotoxicity of this dressing to the commercially available 29 
silver products; Acticoat
TM
, PolyMem Silver
®
 and Flamazine
TM
 cream. Human 30 
keratinocytes (HaCaT and primary HEK) and normal human fibroblasts (NHF) were 31 
exposed to dressings incubated on Nunc
TM
 polycarbonate inserts for 24, 48 and 72 h. Four 32 
different cytotoxicity assays were performed including; Trypan Blue cell count, MTT, 33 
Celltiter-Blue
TM
 and Toluidine Blue surface area assays. The results were expressed as 34 
relative cell viability compared to an untreated control. The cytotoxic effects of Acticoat
TM
 35 
and Flamazine
TM
 cream were dependent on exposure time and cell type. After 24 h 36 
exposure, Acticoat
TM
 and Flamazine
TM
 cream were toxic to all tested cell lines. 37 
Surprisingly, HaCaTs treated with Acticoat
TM
 and Flamazine
TM
 had an improved ability to 38 
survive at 48 and 72 h while HEKs and NHFs had no improvement in survival with any 39 
treatment. The novel silver hydrogel and PolyMem Silver
®
 showed low cytotoxicity to all 40 
tested cell lines at every time interval and these results support the possibility of using the 41 
novel silver hydrogel as a burn wound dressing. Researchers who rely on HaCaT cells as an 42 
accurate keratinocyte model should be aware that they can respond differently to primary 43 
skin cells. 44 
 45 
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Introduction 51 
 52 
The increase of antibiotic resistance in infected wounds has lead to the need to develop 53 
more agents that can be used to treat colonized wounds effectively.  There is substantial 54 
evidence to support the use of silver containing products in infected wound management 55 
and silver has been used for infection treatment for centuries [1] More recently, silver 56 
sulphadiazine (e.g. Flamazine™) is commonly used to treat burn wounds [2]. In the last 57 
decade, a number of silver products have been introduced, which are available in different 58 
formulations and contain various forms of silver including: pure metallic silver and 59 
compounds such as silver phosphate, silver sulfadiazine, silver-sodium carboxymethyl 60 
cellulose and silver chloride [3]. Recent advancements in nano-technology have lead to the 61 
development of nanocrystalline silver, and a new dressing coated with silver nanoparticles 62 
for burn treatment (Acticoat™) [4]. 63 
 64 
Various research groups have studied the cytotoxicity of silver products using different cell 65 
lines and various cytotoxicity assays. In 2004, a cytotoxicity study using MTT assays to 66 
assess the effect of nanocrystalline silver dressing (Acticoat
TM
) on primary human 67 
keratinocytes proposed that Acticoat
TM
 was not appropriate for use as a topical dressing for 68 
cultured skin grafts [5]. Another study used MTT assays on primary human keratinocytes 69 
and fibroblasts  and found Acticoat
TM
 was likely to produce significant cytotoxic effects on 70 
both cell lines, whereas PolyMem Silver
®
 showed the least toxicity compared to other 71 
silver-based dressings tested [6]. Our research group previously found that Silvazine
TM
 72 
(which has ceased production) and its replacement Flamazine
TM
 cream, had cytotoxic 73 
effects on HaCaT cells demonstrated by a Toluidine Blue staining assay [7].  PolyMem 74 
Silver
®
 was found to have low toxicity on HaCaT cells assessed by counting surviving cells 75 
after incubation with treatments [8].  76 
 77 
Recently, a dressing containing silver nanoparticles (SNPs) has been developed by our 78 
research group [9], which is composed of 2-acrylamido-2-methylpropane sulfonic acid 79 
(AMPS) sodium salt hydrogel. The hydrogel acts to provide a moist environment to 80 
stimulate healing, while absorbing wound exudate during the healing process. It feels cool 81 
to touch, which may reduce the pain of wounds. The transparency of the hydrogel enables 82 
observation of the wound healing process. Silver has been incorporated into the dressing to 83 
help prevent wound infection. Although hydrogels have been used previously on burns to 84 
 4 
keep them moist and silver-containing products have also been used in burn care, this novel 85 
treatment combines both advantages in the one dressing. It is also relatively economical to 86 
produce. The antibacterial activity of the novel silver dressing against MRSA and P. 87 
aeruginosa has been evaluated using bactericidal measurement (broth culture and plate 88 
count method) [9] and the results support the possibility of using 5 mM silver hydrogels as 89 
antimicrobial burn wound dressings.  90 
 91 
In this study, the cytotoxicity of the novel silver hydrogel dressing (containing 5 mM silver) 92 
was compared to the commercially available silver products: Acticoat
TM
, PolyMem Silver
®
 93 
and Flamazine
TM
 cream, with neat AMPS hydrogel (containing no silver) used as a negative 94 
control. Three cell monolayer culture systems were compared: HaCaT (a human 95 
keratinocyte immortalised cell line), HEK (primary human epidermal keratinocytes) and 96 
NHF (primary normal human fibroblasts), to investigate the cytotoxicity of the silver agents.  97 
 98 
  99 
 5 
Methods 100 
 101 
Cytotoxicity assessment  102 
 103 
Burn wound products 104 
Three common silver-containing burn treatments were used in this experiment as a 105 
comparison for the silver hydrogel dressing: Acticoat
TM
, PolyMem Silver
®
 and Flamazine
TM
 106 
cream (Figure 1, Table 1). The neat hydrogel (containing no silver) served as a negative 107 
control. 108 
 109 
Cell culture systems   110 
HaCaT cells were a gift from Dr N. Fusenig (German Cancer Research Centre, Heidelberg, 111 
Germany) [10]. The primary keratinocytes and fibroblasts were obtained from foreskin 112 
surgical discards obtained with institutional ethics approval. Both keratinocyte cell lines 113 
were cultured on 35 cm diameter tissue culture plates at a seeding density of 5,000 cells/cm
2
 114 
in 2 mL of growth medium. HaCaTs grew in Roswell Park Memorial Institute (RPMI) 115 
media (Gibco, Australia) containing 10% fetal bovine serum (FBS) and 1% antibiotic-116 
antimycotic (Gibco, Australia).  HEKs were grown in serum-free medium (SFM) 117 
supplemented with 0.15 ng/mL Epidermal Growth Factor (EGF), Bovine Pituitary Extract 118 
(BPE) and antibiotic/antimycotic (AA). The seeding density of NHF was 3,500 cells/cm
2
 in 119 
Dulbecco's Modified Eagle Medium (DMEM) (Gibco, Australia) containing 30 mM Hepes, 120 
10% FBS and AA. Cells were grown for 5 days at 37
o
C in 5% CO2 to achieve 95-100% 121 
confluency, with medium changed at day 1 and day 4. 122 
 123 
Experimental design 124 
A cytotoxicity testing method using polycarbonate cell culture inserts developed by our 125 
research group [8] was applied to a monolayer tissue culture system of cells. In brief, the 126 
novel dressings and silver agents were individually placed on top of a permeable Nunc
TM
 127 
polycarbonate cell culture insert and were incubated on the cell monolayer in 2.5 mL of 128 
culture media for different time intervals (24, 48 and 72 h). The original size of each 129 
dressing varied in order to obtain a 1.0 x 1.0 cm
2
 swelled dressing after 24 h of incubation 130 
(Figure 1). Flamazine
TM
 cream (200 mg) was spread on top of the membrane to an area of 131 
1.0 x 1.0 cm
2
 and the control contained only the polycarbonate insert, with no dressing. 132 
After the incubation times (24, 48 and 72 h), the inserts carrying the dressings were taken 133 
 6 
off and cell morphology images were taken using a SONY, SLT-A55V digital camera (Sony 134 
Corporation of America, USA) attached to an OLYMPUS CKX41 light microscope 135 
(Olympus America Inc, USA).  136 
  137 
Cytotoxicity assays  138 
Initially, four different cytotoxicity assays were conducted using HaCaT cells which are 139 
easy to handle and have an unlimited supply, in order to choose the best assay for further 140 
studies with HEK, NHF and HaCaT at different exposure time intervals. After 24 h 141 
treatment of HaCaT cells, the four different cytotoxicity assays conducted were; Trypan 142 
Blue cell count, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide, 143 
Sigma, USA), CellTiter-Blue
TM 
(Promega, USA) and Toluidine Blue surface area 144 
assessment. On the basis of these results, MTT and surviving cell count assays were carried 145 
out for the 48 h and 72 h exposures of HaCaT and 24, 48 and 72 h exposures of treatment to 146 
HEK and NHF cells. Additionally, we used cell counts from light microscope (LM) photos 147 
to assay the cell density of the monolayer cell lines; HaCaT and HEK to verify the MTT 148 
assay results as MTT assays measure cell metabolism, not necessarily cell number. 149 
 150 
Trypan Blue cell count  151 
After the treatments were incubated with the HaCaT, HEK or NHF cells, any dead cells on 152 
the culture plates were washed off and photos were taken to observe the morphology of the 153 
cells. The cells were then trypsinized, collected, spun down and resuspended in the culture 154 
medium. After mixing 1:1 with Trypan Blue, dead blue cells were excluded from the 155 
haemocytometer count. The number of cells from the untreated control represented optimal 156 
cell survival (100%) and the relative surviving cells of each treatment were calculated using 157 
the following equation:  158 
 159 
 Relative cell viability (%)  =  
                              
                               
   x 100%   160 
  161 
MTT assay 162 
After treatment, the culture medium was removed and cells were gently washed. A 1.5 mL 163 
aliquot of 1.0 mg/ml of MTT in DMEM without phenol red was added and the plate was 164 
incubated at 37
o
C for 5 min for HaCaT and HEK cells and 10 min for NHF cells. MTT 165 
solution was then removed and replaced with 2.5 ml of dimethylsulfoxide solution (10:1.25 166 
 7 
of DMSO:glycine buffer, pH 10.5). A 200 µl aliquot of the solution was added to a 96-well 167 
plate and the A570nm of the solution was measured using a FLUOstar Omega microplate 168 
reader (BMG LABTECH, Germany). The relative cell viability is proportional to the 169 
absorbance and was calculated using the equation below with the untreated control used to 170 
approximate 100% cell viability: 171 
 172 
 Relative cell viability (%)  =  
                
                 
   x 100%    173 
 174 
CellTiter-Blue
TM
 Assay  175 
The culture medium was removed and replaced with 2.0 ml of fresh medium. A 400 µl 176 
aliquot of the CellTiter-Blue
TM
 reagent was added and the plate was incubated for 20 min at 177 
37°C. Aliquots of 100 µl were added to a 96-well plate and the cellular fluorescence 178 
excitation at 544 nm and emission at 590 nm was measured using a FLUOstar Omega 179 
microplate reader. The background fluorescence was measured and the untreated control 180 
fluorescence was taken to be 100% cell survival. The relative cell viability of each treatment 181 
was proportional to the fluorescence values and was calculated using the following 182 
equation: 183 
 184 
 Relative cell viability (%)  = 
                                 
                                  
   x 100% 185 
 186 
Toluidine Blue surface area assessment 187 
The assessment of Toluidine Blue stained surface area of cell growth is a method previously 188 
developed by our research group [7]. In brief, after treatment, the culture medium was 189 
removed and the dead cells were washed off. Cells were stained with 400 µl of 1% 190 
Toluidine Blue in 1% borax buffer for 10 min on a shaker at 100 rpm. The dye was removed 191 
and the cells were thoroughly washed with PBS and then air dried. Digital photos of the 192 
plates were taken and the stained surviving cell areas were measured using Image Pro Plus 193 
v5.1 software (Media Cybernetics Inc., Silver Spring, USA). The relative cell viability (%) 194 
of each treatment was calculated using the equation below: 195 
 196 
 Relative cell viability (%)  =   
                                   
               
   x 100%   197 
 198 
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Cell count from light microscope (LM) photos 199 
Counting cells from LM photos was used to estimate the relative cell density (%) of 200 
surviving cells compared to the control. This was an extra control to verify the results from 201 
the MTT assay, which assesses cell metabolism as an indicator of cell number. The ImageJ 202 
program (version 1.45s) was used for the creation of grids on the morphology photos of 203 
cells. Single cells were then counted manually via the software. The relative cell density (%) 204 
was calculated using the equation: 205 
 206 
 Relative cell density (%)  =  
               
                
   x 100%     207 
 208 
Statistical analysis 209 
 210 
Three independent experiments were performed for each cytotoxicity assay. Differences 211 
between samples and the control were evaluated with One-way analysis of variance 212 
(ANOVA) and the Tukey’s Multiple Comparison Test using GraphPad Prism version 5.03. 213 
Statistically significant differences were set at p < 0.01 (99% confidence).  214 
 215 
  216 
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Results 217 
 218 
Comparison of four different cytotoxicity assays  219 
Of the four different cytotoxicity assays, the MTT assay is considered the fastest assay and 220 
has relatively low cost, with good sensitivity and low variability. Manual cell counts are 221 
time-consuming and can be prone to human error, the Cell Titer-Blue assay is easy but 222 
expensive and has low sensitivity and the Toluidine Blue staining assay has low sensitivity 223 
and accuracy for cell viability >90%. It is for these reasons that the MTT assay was selected 224 
as the best assay to conduct further work in this study. 225 
 226 
After HaCaT cells were exposed to treatment for 24 h, all assays indicated significant 227 
decreases in cell viability for Acticoat
TM
 and Flamazine
TM
 treatments (Figure 2, p < 0.01). 228 
The neat hydrogel, silver hydrogel and PolyMem silver
®
 were less toxic with an average 229 
cell viability of 89.9-91.7 % compared to Acticoat
TM
 and Flamazine
TM 
 (81.7 and 75.8 % 230 
respectively (p < 0.01) (Figure 2)). There was no significant difference in toxicity between 231 
Acticoat
TM
 and Flamazine
TM
 treatments (p > 0.01) or between PolyMem Silver
®
, neat 232 
hydrogel and silver hydrogel (p > 0.01). In addition, no dead cell area was observed in 233 
photos of Toluidine Blue staining of cells exposed to PolyMem Silver
®
 and the two 234 
hydrogel treatments, indicating they had no or only slight cytotoxicity. However, photos of 235 
Toluidine Blue staining of Acticoat
TM
 and Flamazine
TM
 treatments showed obvious dead 236 
cell areas (15.3% and 24.2% % dead cell areas, respectively).    237 
 238 
Cytotoxicity of burn products on three human skin cell lines (using MTT and Trypan Blue 239 
cell count assays) 240 
The morphology of the HaCaT, HEK and NHF cells after 24 h treatment is shown in Figure 241 
3. After Acticoat
TM
 (Figure 3b, e, h) and Flamazine
TM
 treatments, dead cells lost contact 242 
with their neighbors, appeared rounded, and floated on top of the living cell monolayer. 243 
Normal morphology was observed after exposure to PolyMem Silver
®
, neat hydrogel and 244 
silver hydrogel (Figure 3c, f, i), similar to the untreated control for all cells (Figure 3a, d, g). 245 
 246 
After 24 h incubation, MTT and Trypan Blue cell count assays indicated that HaCaTs 247 
exposed to Acticoat
TM
 and Flamazine
TM
 had significantly lower cell viability than the 248 
untreated control (73.9-83.0% cell viability, p < 0.01, Figure 4A, a), indicating the relatively 249 
high toxicity of the two burn products. In comparison, the two assays indicated PolyMem 250 
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Silver
®
 and silver hydrogel treatment had no significant difference in cell viability compared 251 
the control (p > 0.01) while neat hydrogel showed slight toxicity (88.2-89.2% cell viability, 252 
p < 0.01). Similar results were found for 24 h incubation of HEK and NHF cells with 253 
treatments, with Acticoat
TM
 and Flamazine
TM
 having statistically significant toxicity 254 
compared to the control (62.8-71.1% and 75.8-82.2% respectively, p < 0.01) and HEK and 255 
NHF cells showing no toxicity with PolyMem Silver
®
, neat hydrogel and silver hydrogel 256 
(Figure 4B, b, C, c). 257 
 258 
However, after 48 and 72 h incubation, MTT and Trypan Blue cell count assays 259 
demonstrated that HaCaT cells exposed to Acticoat
TM
 (Figure 4A, a) and Flamazine
TM
 had 260 
significantly increased cell viability compared to 24 h exposure and the untreated control (p 261 
< 0.01) with a cell viability of 113.8-123.6% (48 h) and 132.0-133.5% (72 h), respectively. 262 
This result was verified by cell counts of LM photos of HaCaTs exposed to Acticoat
TM
 and 263 
Flamazine
TM
 which also showed an increased cell density for the 48 h and 72 h treatments 264 
compared to their 24 h exposures (cell densities of 102.5-109.3% (48 h) and 119.5-127.7% 265 
(72 h), respectively (p < 0.01)), data not shown. For the other dressings, after 48 h and 72 h 266 
exposure of HaCaT cells,  PolyMem Silver
®
 and neat hydrogel had increased toxicity (70.7-267 
87.3% cell viability) and this was significantly different from the untreated control (p < 268 
0.01). The silver hydrogel showed slight toxicity at 48 h (79.9-85.2%, p > 0.01).  269 
 270 
In contrast, for 48 and 72 h exposures of HEK, MTT and Trypan Blue cell count (Figure 4B, 271 
b) results showed that Acticoat
TM
 and Flamazine
TM
 treatments were toxic to cells with a 272 
relative cell viability of 58.0-73.3% (p < 0.01). No toxicity was found for other treatments. 273 
MTT assays of the silver hydrogel with double silver content (10 mM rather than 5mM) 274 
exposed to HEK for 24, 48 and 72 h were also conducted and showed no difference in 275 
relative cell viability and cell density compared to the untreated control (data not shown). 276 
For 48 and 72 h exposures of NHF, MTT and Trypan Blue cell count (Figure 4C, c) results 277 
showed that Acticoat
TM
 treatment slightly increased the cell viability compared to the 24 h 278 
treatment but this difference was not statistically significant compared to the untreated 279 
control (p > 0.01). Flamazine
TM
 treatment gave slightly increased toxicity after 48 and 72 h 280 
exposure compared to the 24 h treatment but no significant difference was observed (p > 281 
0.01). Trypan Blue cell counts indicated no significant difference in cell viability of 282 
PolyMem Silver
®
, neat hydrogel and silver hydrogel treatments compared to the control at 283 
every time interval (p > 0.01). MTT assay results indicated PolyMem Silver
® 
and silver 284 
 11 
hydrogel had no toxicity (p > 0.01), while neat hydrogel showed toxicity at 72 h incubation 285 
(77.47% cell viability, p > 0.01). 286 
 287 
Figure 5 shows the morphology of HaCaT cells after 72 h exposure to treatments. Dead cell 288 
areas were observed with Acticoat
TM
 (Figure 5b) and Flamazine
TM
 treatments. HaCaT cells 289 
treated with Acticoat
TM
 (Figure 5b) and Flamazine
TM
 appeared longer, smaller and denser 290 
compared to the control (Figure 5a). In contrast, the cells treated with PolyMem Silver
®
, 291 
neat hydrogel and silver hydrogel (Figure 5c) seemed to be less dense than the control. 292 
There was an increase in small vacuoles after treatment with Acticoat
TM
 (Figure 5b) and 293 
Flamazine
TM
 in HaCaT cells at longer incubation times compared to at 24 h. For treatments 294 
of HEK and NHF cells at 72 h, obvious dead cells areas were observed for exposures to 295 
Acticoat
TM
 (Figure 5e, h) and Flamazine
TM
 and the morphologies were similar to results of 296 
the treatments at 24 h except the dead cell areas were larger. Normal morphology was 297 
observed for both primary cell lines after exposure to PolyMem Silver
®
, neat hydrogel and 298 
silver hydrogel (Figure 5f, i), however the cells were slightly less dense compared to the 299 
controls (Figure 5d, g). NHF cells showed signs of oxidative stress (small vacuoles) after 300 
every silver treatment at 72 h (Figure 5h, i). The higher the silver content in the agents, the 301 
more small vacuoles were observed. 302 
 303 
 304 
  305 
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Discussion 306 
 307 
The MTT and Trypan Blue cell count assays showed that HaCaT cells had improved ability 308 
to survive exposure to the more toxic Acticoat
TM
 and Flamazine
TM
 treatments after 48 h and 309 
72 h, whereas there was significant cell death at 24 h. This surprising result was confirmed 310 
by the cell counts at 48 and 72 h, in which the cell densities after Acticoat
TM
 and 311 
Flamazine
TM
 treatments had increased (not just the metabolism of the remaining cells, as 312 
measured by MTT). Similar increases in HaCaT cell survival were found using a clonogenic 313 
assay after an 8 day exposure to silver nanoparticles [11]. The growth enhancement of the 314 
HaCaT cells appeared to be less after Flamazine
TM
 treatment compared to Acticoat
TM
 and 315 
this may have been due to Flamazine
TM
 inhibiting the available growth area on the plate as 316 
seen with the Toluidine Blue staining. No improvements in survival were observed from the 317 
treatments of the low toxicity agents PolyMem Silver
®
, neat hydrogel and silver hydrogel in 318 
HaCaT cells.  319 
 320 
The reason for this improvement of survival of HaCaT cells under toxic conditions is 321 
unclear. HaCaTs possibly have developed a more altered phenotype which may improve 322 
their survival ability under stressful conditions, whereas NHF and HEK seem to be more 323 
sensitive to toxic agents and showed no improvement of survival after any treatment. HEK 324 
cells especially seemed to be the most sensitive to Acticoat
TM 
and Flamazine
TM
, with higher 325 
toxicity seen at every time interval. High variability was also seen for most HEK 326 
experiments, due to the difficulty in differentiating live and dead HEK cells stained with 327 
Trypan Blue. Importantly, the HEK toxicity results differed between cells from different 328 
passage numbers (e.g. from passage number 2 versus 4) and this may suggest that immortal 329 
cell lines (like HaCaTs) which are able to survive for an extended time have developed an 330 
altered phenotype with enhanced growth ability, enabling improved survival after exposure 331 
to toxic agents. One possibility is that these cells are better able to produce stimulating 332 
factors to enhance the growth of neighboring cells in response to reactive oxygen species 333 
which are produced by silver nanoparticles [12]. HaCaT cells have been shown to contain 334 
relatively high natural antioxidant (e.g. GSH) levels which help them to survive nanoparticle 335 
generated oxidative stress [11].  More studies on other immortal cell lines are required to 336 
prove this hypothesis.  337 
 338 
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In this study, PolyMem Silver
®
, neat hydrogel and silver hydrogel treatments showed no 339 
significant NHF or HEK toxicity for all time intervals. The only exception to this was the 340 
neat hydrogel, which appeared to cause significant toxicity to NHF cells at 72 h for an 341 
unknown reason. NHF cells also had an increased number of vacuoles after exposure to 342 
silver hydrogel at 72 h, confirming that they were under some stress. However, significant 343 
toxicity to HaCaT cells was seen at most time points for the PolyMem Silver
®
, neat 344 
hydrogel and silver hydrogel treatments.  345 
 346 
The significantly different results found between immortal keratinocytes (HaCaTs) and 347 
primary keratinocytes (HEK) is an important warning for many researchers who use 348 
HaCaTs as a keratinocyte model and suggests cell survival study results obtained using 349 
solely HaCaT cells may not be indicative of the true skin response to treatment. Given that 350 
the primary keratinocyte and fibroblast cell lines showed little or no toxicity with the silver 351 
hydrogel treatment, this indicates that it may be a beneficial dressing for the management of 352 
burn injuries in the future. 353 
 354 
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Table 1: Burn wound products tested 407 
Product  Manufacturer Basic composition Silver form Silver content 
Acticoat
TM
 Smith & Nephew 
(Hull, UK) 
An absorbent polyester core 
laminated between two outer 
layers of silver coated 
polyethylene mesh 
nanocrystalline 
silver 
0.84-1.34 
mg/cm
2
 
PolyMem 
Silver
®
 
Ferris MFG Corp. 
(Burr Ridge, IL, 
US) 
Polyurethane foam containing 
F68, superabsorbent starch 
silver particles minimum 
0.124 mg/ cm
2
 
Flamazine
TM
 Smith & Nephew 
(Hull, UK) 
Cetyl alcohol, distilled water, 
glycerol stearate, liquid paraffin, 
polysorbate 60, polysorbate 80, 
and propylene glycol. 
Silver 
sulfadiazine 
maximum 
0.60 mg /200 
mg cream 
neat AMPS 
hydrogel 
developed by our 
lab 
AMPS sodium salt hydrogel None none 
silver AMPS 
hydrogel 
developed by our 
lab 
AMPS sodium salt hydrogel Silver 
nanoparticle 
maximum 
0.054 mg/cm
2
 
 408 
 409 
 410 
 411 
Figure 1 Photos of burn products tested in this study (top) and of the Nunc
TM
 Polycarbonate 412 
inserts with dressings or cream on top incubated with HaCaT cell cultures for 24 hours 413 
(below); a: Acticoat
TM
, b: PolyMem Silver
®
, c: Flamazine
TM
 cream, d: neat hydrogel, e: 414 
silver hydrogel. 415 
 416 
Figure 2 Relative cell viability (%) of HaCaTs treated with burn wound products for 24 h 417 
compared to untreated cells assessed by four different cytotoxicity assays including: Trypan 418 
Blue cell count, MTT, Celltiter-Blue
TM
, and Toluidine Blue surface area. *denotes a 419 
statistically significant (p < 0.01) difference from the untreated control. 420 
 421 
 Figure 3 Morphology images of 20X HaCaT (a-c), 20X HEK (d-f) and 10X NHF (g-i) 422 
cells after 24 h exposure to treatment: control (a, d, g), Acticoat
TM
 (b, e, h), silver hydrogel 423 
(c, f, i). 424 
 425 
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Figure 4 HaCaT, HEK and NHF cells exposed to burn treatments for 24, 48 and 72 h 426 
determined by: MTT (A-C); Trypan Blue cell count (a-c). Data are expressed as relative cell 427 
viability (%) ± SD of three independent experiments. 
*
denotes a statistically significant (p < 428 
0.01) difference from the untreated control. 429 
 430 
Figure 5 Morphology images of 20X HaCaT (a-c), 20X HEK (d-f) and 10X NHF (g-i) cells 431 
after 72 h exposure to treatments: control (a, d, g), Acticoat
TM
 (b, e, h), silver hydrogel (c, f, 432 
i). 433 
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